|
1
|
Joussen AM, Gardner TW, Kirchhof B and
Ryan SJ (eds): Retinal vascular disease. Section III, Ch. 21,
Retinal Artery Occlusion, pp507-518, 2007.
|
|
2
|
Brown GC and Magargal LE: Central retinal
artery obstruction and visual acuity. Ophthalmology. 89:14–19.
1982.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Landa E, Rehany U and Rumelt S: Visual
functions following recovery from non-arteritic central retinal
artery occlusion. Ophthalmic Surg Lasers Imaging. 35:103–108.
2004.PubMed/NCBI
|
|
4
|
Stanca HT, Petrović Z and Munteanu M:
Transluminal Nd: YAG laser Embolysis - a reasonable method to
reperfuse occluded branch retinal arteries. Vojnosanit Pregl.
71:1072–1077. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Arruga J and Sanders MD: Ophthalmologic
findings in 70 patients with evidence of retinal embolism.
Ophthalmology. 89:1336–13347. 1982.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mitchell P, Wang JJ and Smith W: Risk
factors and significance of finding asymptomatic retinal emboli.
Clin Exp Ophthalmol. 28:13–17. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stanca HT, Suvac E, Munteanu M, Jianu DC,
Motoc AGM, Roşca GC and Boruga O: Giant cell arteritis with
arteritic anterior ischemic optic neuropathy. Rom J Morphol
Embryol. 58:281–285. 2017.PubMed/NCBI
|
|
8
|
Braunstein RA and Gass JD: Branch artery
obstruction caused by acute toxoplasmosis. Arch Ophthalmol.
98:512–513. 1980.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cohen SM, Davis JL and Gass DM: Branch
retinal arterial occlusions in multifocal retinitis with optic
nerve oedema. Arch Ophthalmol. 113:1271–1276. 1995.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lightman DA and Brod RD: Branch retinal
artery occlusion associated with Lyme disease. Arch Ophthalmol.
109:1198–1199. 1991.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Solley WA, Martin DF, Newman NJ, King R,
Callanan DG, Zacchei T, Wallace T, Parks DJ, Bridges W and
Sternberg P Jr: Cat scratch disease: Posterior segment
manifestations. Ophthalmology. 106:1546–1553. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yokoi M and Kase M: Retinal vasculitis due
to secondary syphilis. Jpn J Ophthalmol. 48:65–67. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Klein ML, Jampol LM, Condon PI, Rice TA
and Serjeant GR: Central retinal artery occlusion without
retrobulbar hemorrhage after retrobulbar anesthesia. Am J
Ophthalmol. 93:573–577. 1982.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Newman NJ, Lessell S and Brandt EM:
Bilateral central retinal artery occlusions, disk drusen, and
migraine. Am J Ophthalmol. 107:236–240. 1989.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wallace RT, Brown GC, Benson W and
Sivalingham A: Sudden retinal manifestations of intranasal cocaine
and methamphetamine abuse. Am J Ophthalmol. 114:158–160.
1992.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Joussen AM, Gardner TW, Kirchhof B and
Ryan SJ (eds): Retinal vascular disease. Section III, Ch. 21,
Central Retinal Vein Occlusion, pp443-461, 2007.
|
|
17
|
Hayreh SS, Zimmerman MB and Podhajsky P:
Incidence of various types of retinal vein occlusion and their
recurrence and demographic characteristics. Am J Ophthalmol.
117:429–441. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fong A, Schatz H, McDonald HR, Burton TC,
Maberley AL, Joffe L, Zegarra H, Nadel AJ and Johnson RN: Central
retinal vein occlusion in young adults (papillophlebitis). Retina.
11:3–11. 1991.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Golub BM, Sibony PA and Coller BS: Protein
S deficiency associated with central retinal artery occlusion. Arch
Ophthalmol. 108(918)1990.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nelson ME, Talbot JF and Preston FE:
Recurrent multiple-branch retinal arteriolar occlusions in a
patient with protein C deficiency. Graefes Arch Clin Exp
Ophthalmol. 227:443–447. 1989.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Weger M, Renner W, Pinter O, Stanger O,
Temmel W, Fellner P, Schmut O and Haas A: Role of factor V Leiden
and prothrombin 20210A in patients with retinal artery occlusion.
Eye (Lond). 17:731–734. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cobo-Soriano R, Sanchez-Ramon S, Aparicio
MJ, Teijeiro MA, Vidal P, Suarez-Leoz M, Rodriguez-Mahou M,
Rodriguez-Huerta A, Fernández-Cruz E and Cortés C: Antiphospholipid
antibodies and retinal thrombosis in patients without risk factors:
A prospective case-control study. Am J Ophthalmol. 128:725–732.
1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cahill M, Karabatzaki M, Meleady R, Refsum
H, Ueland P, Shields D, Mooney D and Graham I: Raised plasma
homocysteine as a risk factor for retinal vascular occlusive
disease. Br J Ophthalmol. 84:154–157. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pianka P, Almog Y, Man O, Goldstein M,
Sela BA and Loewenstein A: Hyperhomocystinemia in patients with
nonarteritic anterior ischemic optic neuropathy, central retinal
artery occlusion, and central retinal vein occlusion.
Ophthalmology. 107:1588–1592. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dean L: Methylenetetrahydrofolate
Reductase Deficiency. Mar 8, 2012 [Updated 2016 Oct 27]. In: Pratt
VM, McLeod HL, Rubinstein WS, et al (eds). Medical Genetics
Summaries [Internet]. Bethesda (MD), National Center for
Biotechnology Information (US), 2012. Available from urihttps://www.ncbi.nlm.nih.gov/books/NBK66131/simplehttps://www.ncbi.nlm.nih.gov/books/NBK66131/.
Accessed on July 10, 2020.
|
|
26
|
Humphrey LL, Fu R, Rogers K, Freeman M and
Helfand M: Homocysteine level and coronary heart disease incidence:
A systematic review and Meta-analysis. Mayo Clin Proc.
83:1203–1212. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
den Heijer M, Rosendaal FR, Blom HJ,
Gerrits WB and Bos GM: Hyperhomocysteinemia and venous thrombosis:
A meta-analysis. Thromb Haemost. 80:874–877. 1998.PubMed/NCBI
|
|
28
|
Kupferminc MJ, Eldor A, Steinman N, Many
A, Bar-Am A, Jaffa A, Fait G and Lessing JB: Increased frequency of
genetic thrombophilia in women with complications of pregnancy. N
Engl J Med. 340:9–13. 1999.PubMed/NCBI View Article : Google Scholar
|
|
29
|
McLornan D, Percy M and McMullin MF: JAK2
V617F: A single mutation in the myeloproliferative group of
disorders. Ulster Med J. 75:112–119. 2006.PubMed/NCBI
|
|
30
|
Jackson TL and Moorfields Eye Hospital:
Moorfields Manual of Ophthalmology. Philadelphia, PA, Mosby
Elsevier, 2008.
|
|
31
|
Munteanu M, Rosca C and Stanca HT:
Sub-inner limiting membrane hemorrhage in a patient with Terson
syndrome. Int Ophthalmol. 39:461–464. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Holmes MV, Newcombe P, Hubacek JA, Sofat
R, Ricketts SL, Cooper J, Breteler MM, Bautista LE, Sharma P,
Whittaker JC, et al: Effect modification by population dietary
folate on the association between MTHFR genotype, homocysteine, and
stroke risk: A meta-analysis of genetic studies and randomised
trials. Lancet. 378:584–594. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shiran A, Remer E, Asmer I, Karkabi B,
Zittan E, Cassel A, Barak M, Rozenberg O, Karkabi K and Flugelman
MY: Association of vitamin B12 deficiency with homozygosity of the
TT MTHFR C677T genotype, hyperhomocysteinemia, and endothelial cell
dysfunction. Isr Med Assoc J. 17:288–292. 2015.PubMed/NCBI
|
|
34
|
van der Put NM, Gabreels F, Stevens EM,
Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ:
A second common mutation in the methylenetetrahydrofolate reductase
gene: An additional risk factor for neural-tube defects? Am J Hum
Genet. 62:1044–1051. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Clarke R, Bennett DA, Parish S, Verhoef P,
Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell
JC, et al: Homocysteine and coronary heart disease: Meta-analysis
of MTHFR case-control studies, avoiding publication bias. PLoS Med.
9(e1001177)2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Campbell PJ, Scott LM, Buck G, Wheatley K,
East CL, Marsden JT, Duffy A, Boyd EM, Bench AJ, Scott MA, et al:
United kingdom myeloproliferative disorders study group; Medical
research council adult leukaemia working party; Australasian
leukaemia and lymphoma group definition of subtypes of essential
thrombocythaemia and relation to polycythaemia vera based on JAK2
V617F mutation status: A prospective study. Lancet. 366:1945–1953.
2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Katz D and Beilin Y: Disorders of
coagulation in pregnancy. Br J Anaesth. 115 (Suppl 2):ii75–ii88.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Brenner B: Haemostatic changes in
pregnancy. Thromb Res. 114:409–414. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
James AH: Pregnancy and thrombotic risk.
Crit Care Med. 38(Suppl 2):S57–S63. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Abbassi-Ghanavati M, Greer LG and
Cunningham FG: Pregnancy and laboratory studies: A reference Table
for clinicians. Obstet Gynecol. 114:1326–1331. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cerneca F, Ricci G, Simeone R, Malisano M,
Alberico S and Guaschino S: Coagulation and fibrinolysis changes in
normal pregnancy. Increased levels of procoagulants and reduced
levels of inhibitors during pregnancy induce a hypercoagulable
state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol
Reprod Biol. 73:31–36. 1997.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Prisco D, Ciuti G and Falciani M:
Hemostatic changes in normal pregnancy. Hematol Meet Reports
(Formerly Haematol Reports). 1:1–5. 2005.
|
|
43
|
O'Riordan MN and Higgins JR: Haemostasis
in normal and abnormal pregnancy. Best Pract Res Clin Obstet
Gynaecol. 17:385–396. 2003.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bremme K, Ostlund E, Almqvist I, Heinonen
K and Blombäck M: Enhanced thrombin generation and fibrinolytic
activity in normal pregnancy and the puerperium. Obstet Gynecol.
80:132–137. 1992.PubMed/NCBI
|
|
45
|
Szecsi PB, Jørgensen M, Klajnbard A,
Andersen MR, Colov NP and Stender S: Haemostatic reference
intervals in pregnancy. Thromb Haemost. 103:718–727.
2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Comp PC, Thurnau GR, Welsh J and Esmon CT:
Functional and immunologic protein S levels are decreased during
pregnancy. Blood. 68:881–885. 1986.PubMed/NCBI
|
|
47
|
Marlet J, Ankri A, Charuel JL,
Ghillani-Dalbin P, Perret A, Martin-Toutain I, Haroche J, Amoura Z,
Musset L and Miyara M: Thrombophilia associated with anti-DFS70
autoantibodies. PLoS One. 10(e0138671)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ochs RL, Muro Y, Si Y, Ge H, Chan EK and
Tan EM: Autoantibodies to DFS 70 kd/transcription coactivator p75
in atopic dermatitis and other conditions. J Allergy Clin Immunol.
105:1211–1220. 2000.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Okamoto M, Ogawa Y, Watanabe A, Sugiura K,
Shimomura Y, Aoki N, Nagasaka T, Tomita Y and Muro Y:
Autoantibodies to DFS70/LEDGF are increased in alopecia areata
patients. J Autoimmun. 23:257–266. 2004.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Shinohara T, Singh DP and Chylack LT Jr:
Review: Age-related cataract: Immunity and lens epithelium-derived
growth factor (LEDGF). J Ocul Pharmacol Ther. 16:181–191.
2000.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yamada K, Senju S, Shinohara T, Nakatsura
T, Murata Y, Ishihara M, Nakamura S, Ohno S, Negi A and Nishimura
Y: Humoral immune response directed against LEDGF in patients with
VKH. Immunol Lett. 78:161–168. 2001.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Watanabe A, Kodera M, Sugiura K, Usuda T,
Tan EM Takasaki Y, Tomita Y and Muro Y: Anti-DFS70 antibodies in
597 healthy hospital workers. Arthritis Rheum. 50:892–900.
2004.PubMed/NCBI View Article : Google Scholar
|
